Bain Capital Life Sciences LP purchased $6.4M worth of shares in Aptinyx, Inc. in June 2018

Jul 08, 2018
Insider Transactions
Background Information
Aptinyx Inc. is a clinical stage biopharmaceutical company. It engages in the discovery, development, and and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. The company was founded by Norbert G. Riedel and Joseph R. Moskal in June 2015 and is headquartered in Evanston, IL.
Bain Capital Life Sciences primarily focuses on controlling equity investments, inflection capital, growth capital and fallen angels. The firm invests biopharmaceutical, medical device, diagnostics and enabling life science technology companies. The firm may also recommend other types of investments consistent with the respective of their fund's investment strategy and objectives.